Omalizumab

1 Drug classified under this active ingredient

Omalizumab 150 mg.
VIALS: 1 + 1 amp. solv. Adults
over 12 yrs: Single use only.
Xolair 150 to 375 mg for moderate
persistent asthma and 150 to 600 mg
for severe persistent asthma is
administered SC every 2 or 4 weeks.
Mod. to severe persist. asth. with +ive skin
test/in vitro reactiv. to peren.aeroallergen
when sympts. inad. controlled by inhal.
corticoster.
C/I: Severe hypersens.